IbuprofenAspirinPlatelet Aggregation InhibitorsTiclopidineAnti-Inflammatory Agents, Non-SteroidalPlatelet AggregationPlatelet Function TestsDrug Therapy, CombinationBlood PlateletsCyclooxygenase InhibitorsHemorrhageThrombosisThromboxane B2AnticoagulantsAnalgesics, Non-NarcoticPurinergic P2Y Receptor AntagonistsAcetaminophenFibrinolytic AgentsPlatelet ActivationReceptors, Purinergic P2Y12DipyridamoleTreatment OutcomeThienopyridinesCoronary ThrombosisNaproxenBleeding TimeWarfarinThiophenesAcute Coronary SyndromePhenprocoumonStrokeSalicylatesPlatelet Glycoprotein GPIIb-IIIa ComplexThromboxanesDouble-Blind MethodDiclofenacStentsTime FactorsAngioplasty, Balloon, CoronaryRisk FactorsCyclooxygenase 2 InhibitorsMyocardial InfarctionDose-Response Relationship, DrugCyclooxygenase 1Administration, OralProspective StudiesAntipyreticsDrug InteractionsPlatelet CountProstaglandin-Endoperoxide SynthasesDrug-Eluting StentsDuctus Arteriosus, PatentGastrointestinal HemorrhagePostoperative HemorrhageDrug ResistanceSulfinpyrazoneIndomethacinSecondary PreventionThromboembolismLactonesFollow-Up StudiesDrug Administration ScheduleTetrazolesPremedicationRandomized Controlled Trials as TopicAdenosine DiphosphateTablets, Enteric-CoatedSodium SalicylateKetoprofenCoronary Artery DiseaseRisk AssessmentThromboxane A2RecurrenceTherapeutic EquivalencyHeparinCross-Over StudiesEpoprostenolCyclooxygenase 2Drug CombinationsIschemic Attack, TransientCerebrovascular Disorders